HGS Q2 margin rises to 13.1% as H1 loss reaches Rs 78.7 crore
Key highlights
- HGS's Q2 FY2027 total EBITDA rose 36.5% sequentially to Rs 158.8 crore.
- HGS's Q2 FY2027 total EBITDA margin increased to 13.1% from 9.7% in Q1 FY2027.
- HGS's H1 FY2027 continuing-operations loss widened to Rs 78.7 crore from Rs 73.3 crore.
- HGS's H1 FY2027 revenue from operations declined 1.0% year on year to Rs 2,126.5 crore.
powered by IRIS

HGS reported a 13.1% total EBITDA margin in Q2 FY2027, up from 9.7% in Q1 FY2027, as total EBITDA rose 36.5% sequentially to Rs 158.8 crore; however, its H1 FY2027 loss after tax from continuing operations widened to Rs 78.7 crore from Rs 73.3 crore a year earlier.
Know Hinduja Global Solutions inside out
Results, valuation, peers and who's buying, in one view.
How did HGS's Q2 FY2027 margin and earnings change?
HGS's Q2 FY2027 total EBITDA margin increased by 3.4 percentage points sequentially to 13.1%, while total EBITDA rose to Rs 158.8 crore from Rs 116.3 crore in Q1 FY2027. EBITDA, or earnings before interest, tax, depreciation and amortisation, includes other income in HGS's presentation. The margin was also 0.2 percentage points above the 12.9% reported in Q2 FY2026, when total EBITDA was Rs 158.0 crore.
HGS's Q2 loss after tax improved to Rs 12.4 crore from Rs 66.3 crore in Q1 FY2027 and Rs 27.0 crore in Q2 FY2026. Profit before tax, or PBT, was a loss of Rs 9.6 crore, compared with losses of Rs 52.8 crore sequentially and Rs 14.1 crore a year earlier. Operating expenses fell to Rs 1,055.7 crore from Rs 1,084.9 crore in Q1 FY2027, while depreciation declined to Rs 117.5 crore from Rs 123.6 crore.
Why did HGS's H1 FY2027 loss widen despite the Q2 rebound?
HGS's H1 FY2027 loss after tax from continuing operations widened by Rs 5.4 crore year on year to Rs 78.7 crore because the first-half result remained loss-making despite the improved second quarter. PBT was a loss of Rs 62.4 crore in H1 FY2027, compared with a Rs 40.6 crore loss in H1 FY2026. The Q2 result reduced the loss relative to Q1 FY2027 but did not return HGS to first-half profitability.
The reported total loss changed more sharply because H1 FY2026 included Rs 57.5 crore of profit from discontinued operations, whereas H1 FY2027 recorded no profit or loss from discontinued operations. Total profit after tax, or PAT, was consequently a Rs 78.7 crore loss in H1 FY2027, compared with a Rs 15.8 crore loss a year earlier. The continuing-operations loss widened by Rs 5.4 crore, while the total loss widened by Rs 62.9 crore.
HGS generated Rs 2,126.5 crore of H1 revenue from operations, down 1.0% from Rs 2,147.3 crore a year earlier, while operating expenses rose to Rs 2,140.5 crore from Rs 2,092.5 crore. Total other income increased 10.0% to Rs 289.1 crore, but total EBITDA fell 13.4% to Rs 275.1 crore. The total EBITDA margin decreased to 11.4% from 13.2% over the same period.
Got a follow-up? Ask IRIS
What does HGS's Q2 FY2027 revenue mix show?
HGS derived 54% of Q2 FY2027 operating revenue from CX Services and 46% from Digital & Media Services, against revenue from operations of Rs 1,076.2 crore. The presentation does not provide prior-period source splits, so it does not show whether either source gained or lost share from Q1 FY2027 or Q2 FY2026.
By customer vertical, TMT accounted for 45% of Q2 FY2027 operating revenue, making it the largest disclosed category. CG & Retail contributed 21%, BFSI 15%, Public Sector 10%, Health & Life Science 3%, and Others 5%. TMT and CG & Retail together represented 66% of operating revenue based on their disclosed 45% and 21% shares.
Revenue from operations increased 2.5% sequentially from Rs 1,050.4 crore in Q1 FY2027 to Rs 1,076.2 crore in Q2 FY2027, but was 1.4% below Rs 1,091.0 crore in Q2 FY2026. Total income rose 1.1% sequentially to Rs 1,214.5 crore, even as total other income declined 8.3% from Rs 150.8 crore in Q1 FY2027 to Rs 138.3 crore in Q2 FY2027. Total EBITDA therefore increased in the quarter despite lower other income than in the preceding quarter.
What balance-sheet and cash-flow changes should readers track at HGS?
HGS had total assets of Rs 11,582.5 crore at September 2026, compared with Rs 11,563.6 crore at March 2026, while cash and bank balances declined to Rs 528.1 crore from Rs 568.9 crore. Current financial assets rose to Rs 6,445.5 crore from Rs 6,177.5 crore; HGS says financial assets include investments, loans given and bank balances. Trade receivables fell to Rs 800.1 crore from Rs 871.8 crore.
HGS's days sales outstanding, or DSO, increased to 68 days in Q2 FY2027 from 61 days in Q2 FY2026, despite the lower trade-receivables balance at September 2026 than at March 2026. Current borrowings increased to Rs 1,142.9 crore at September 2026 from Rs 1,066.3 crore at March 2026, and non-current borrowings rose to Rs 263.5 crore from Rs 227.7 crore. Total equity increased to Rs 8,447.3 crore from Rs 8,436.1 crore.
Cash from operating activities was Rs 108.4 crore for the period ending September 30, 2026, while capital-expenditure investments were Rs 81.9 crore and cash from financing activities was an outflow of Rs 169.5 crore. These figures cover a period ending September 30, 2026, while the comparison column ends March 31, 2026. Net cash and cash equivalents decreased by Rs 92.6 crore during the September period, ending at Rs 528.1 crore; interest paid was Rs 84.0 crore and lease liabilities and borrowings accounted for a further Rs 65.3 crore outflow.
Conclusion
HGS's Q2 FY2027 figures show a sequential recovery in total EBITDA and a smaller quarterly loss, with the margin rising to 13.1% and total PAT loss narrowing to Rs 12.4 crore. The half-year figures remain lower than the prior year: revenue from operations declined 1.0%, total EBITDA fell 13.4%, and the continuing-operations loss increased to Rs 78.7 crore.
The unresolved matters in the disclosed September 2026 data are whether the Q2 total EBITDA of Rs 158.8 crore and 13.1% margin can be maintained, whether revenue can recover above the Rs 1,091.0 crore recorded in Q2 FY2026, and how DSO of 68 days and increased borrowings develop. HGS's presentation provides no forward earnings target or scheduled operating milestone.


